MCID: STR009
MIFTS: 12

Stromal Predominant Kidney Wilms' Tumor

Categories: Cancer diseases, Nephrological diseases

Aliases & Classifications for Stromal Predominant Kidney Wilms' Tumor

MalaCards integrated aliases for Stromal Predominant Kidney Wilms' Tumor:

Name: Stromal Predominant Kidney Wilms' Tumor 12
Stromal Predominant Kidney Wilms Tumor 17
Stromal Predominant Renal Wilms Tumor 12
Stromal Predominant Wilms' Tumor 72

Classifications:



External Ids:

Disease Ontology 12 DOID:5191
NCIt 50 C9148
UMLS 72 C0279610

Summaries for Stromal Predominant Kidney Wilms' Tumor

MalaCards based summary : Stromal Predominant Kidney Wilms' Tumor, is also known as stromal predominant kidney wilms tumor, and has symptoms including abdominal pain The drugs Vincristine and Etoposide have been mentioned in the context of this disorder. Affiliated tissues include kidney.

Related Diseases for Stromal Predominant Kidney Wilms' Tumor

Symptoms & Phenotypes for Stromal Predominant Kidney Wilms' Tumor

UMLS symptoms related to Stromal Predominant Kidney Wilms' Tumor:


abdominal pain

Drugs & Therapeutics for Stromal Predominant Kidney Wilms' Tumor

Drugs for Stromal Predominant Kidney Wilms' Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 21)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
2
Etoposide Approved Phase 3 33419-42-0 36462
3
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
4
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
5
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
6
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
7 Tubulin Modulators Phase 3
8 Alkylating Agents Phase 3
9
Liposomal doxorubicin Phase 3 31703
10 Antineoplastic Agents, Phytogenic Phase 3
11 Anti-Bacterial Agents Phase 3
12 Immunosuppressive Agents Phase 3
13 Antibiotics, Antitubercular Phase 3
14 Anti-Infective Agents Phase 3
15 Topoisomerase Inhibitors Phase 3
16 Immunologic Factors Phase 3
17 Antimitotic Agents Phase 3
18 Nucleic Acid Synthesis Inhibitors Phase 3
19 Antirheumatic Agents Phase 3
20 Etoposide phosphate Phase 3
21 Antineoplastic Agents, Alkylating Phase 3

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Nephroblastoma (Wilms Tumour) Clinical Trial And Study Unknown status NCT00047138 Phase 3 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;vincristine sulfate
2 Investigation of DICER1 in Cystic Nephroma and Cystic Partially Differentiated Nephroblastoma Completed NCT01353300

Search NIH Clinical Center for Stromal Predominant Kidney Wilms' Tumor

Genetic Tests for Stromal Predominant Kidney Wilms' Tumor

Anatomical Context for Stromal Predominant Kidney Wilms' Tumor

MalaCards organs/tissues related to Stromal Predominant Kidney Wilms' Tumor:

41
Kidney

Publications for Stromal Predominant Kidney Wilms' Tumor

Articles related to Stromal Predominant Kidney Wilms' Tumor:

# Title Authors PMID Year
1
Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15. 38
27213811 2016

Variations for Stromal Predominant Kidney Wilms' Tumor

Expression for Stromal Predominant Kidney Wilms' Tumor

Search GEO for disease gene expression data for Stromal Predominant Kidney Wilms' Tumor.

Pathways for Stromal Predominant Kidney Wilms' Tumor

GO Terms for Stromal Predominant Kidney Wilms' Tumor

Sources for Stromal Predominant Kidney Wilms' Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....